CClinicalTrials.gg
Active, not recruitingNCT07458750Updated Jul 15, 2026

Neuromuscular Electrical Stimulation and Voluntary Muscle Contraction in Chronic Hemiplegic Stroke Patients

An interventional study of Conventional physiotherapy and Neuromuscular electrical stimulation and voluntary muscle contraction in Stroke, sponsored by University of Lahore. Active, not recruiting at 1 site in Pakistan. Open to participants aged 43 Years to 83 Years. Per ClinicalTrials.gov, last updated 2026-07-15.

Sponsored by University of Lahore · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Feb 2025, registered Mar 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
43 Years to 83 Years
Sex
All
01

Study summary

This single-blinded randomized controlled trial will be conducted at the Physical Therapy Department of the University of Lahore Teaching Hospital after approval from the Institute Research Ethics Board. Eligible participants will be recruited and randomly allocated into two groups by lottery method: Group A (control group) receiving conventional physical therapy, and Group B (experimental group) receiving neuromuscular electrical stimulation (NEMS) combined with voluntary muscle contraction. NEMS will be applied to the tibialis anterior, extensor hallucis longus, and extensor digitorum longus with standard stimulation parameters, while participants perform active dorsiflexion during stimulation. The assessor will remain blinded to group allocation. Outcome measures including spasticity (Modified Ashworth Scale), active range of motion (goniometer), and muscle strength (manual muscle testing) will be evaluated at baseline, 6 weeks, and 12 weeks.

Read the detailed description

Recruitment: Participants will be recruited from Physical Therapy Department of University of Lahore Teaching Hospital, Lahore Screening: All the referred participants will be assessed for the eligibility criteria.

Patients fulfilling the eligibility criteria will be asked to sign the consent forms before entering them to the study. Randomization and Allocation: All the screened and willing participants will be randomly allocated to two groups (Group A: Experimental group/NEMS + voluntary muscle contraction group. Group B: control group/standard rehabilitation therapy) by lottery method. Blinding: This study was a single blinded study in which assessor was kept blinded Intervention Group A: Comparative Group (Conventional physical therapy) Patients in comparative group will receive conventional approach that will encompass placebo effect application of NEMS, weight bearing , stretching , pnf technique , tapping , passive roms , strength exercise of dorsiflexors Group B : Experiment Group/NEMS+Voluntary muscle contraction group: The participants randomly allocated in Group A will receive the electrical stimulation through electrodes on tibialis anterior, extensor hallucis longus and extensor digitorum longus

.Stimulation parameters will be as follows: pulse width=200 microseconds; on time=5seconds; off time=5seconds; frequency=20Hz; waveform=symmetrical biphasic square wave. The patient will be instructed to produce a voluntary dorsi flexors contraction with the electric pulse The stimulation intensity will adjusted according to each treatment group. All intensities were comfortable for the patients and did not induce fatigue. Any complaints and discomfort during the treatment process in each group will monitored and recorded using a patient record.

Outcome Variables:

  1. Spasticity: Modified Ashworth scale
  2. Active rom: Goniometer
  3. Muscle Grading: Manual muscle testing Data will be assessed by assessor at baseline, at the end of 6th week and at the end of 12th week
02

Conditions studied

  • Stroke

Keywords

  • Hemiplegia
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 25 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of Lahore is the lead sponsor of 223 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
43 Years to 83 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age of between 43 to 83 years of age
  • Diagnosed with chronic stroke (≥6 months in duration) with motor deficits resulting in hemiplegia
  • Mild ankle dorsiflexion possible
  • MAS score of ≤3 for dorsiflexors to the ankle joint
  • Be self-mobility either with or without aids .

Exclusion criteria

Exclusion Criteria:

  • Parkinson's or multiple sclerosis affecting the nervous systems of the body
  • Skeletal disorders that hinder the ability of the limb
  • Pacemaker or any condition which may lead to a contraindication with NMES
  • Spasticity (MAS ≥ 3)
  • Current botulinum toxin injections in the lower limb that developed the spasticity
  • Patients with any cognitive impairment (MMSE \< 24)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Conventional physiotherapy

    Conventional physiotherapy Participants in the comparative group will receive conventional physiotherapy treatment including placebo application of neuromuscular electrical stimulation (NEMS), weight-bearing exercises, stretching, proprioceptive neuromuscular facilitation (PNF) techniques, tapping, passive range of motion (PROM) exercises, and dorsiflexor strengthening exercises. The placebo NEMS will be applied in the same manner as the active stimulation but without any therapeutic current. Each session will be supervised by a physiotherapist. Treatment will be conducted as per the study protocol, and all participants' responses, complaints, and discomforts during the sessions will be monitored and recorded using a patient record sheet.

    Other: Conventional physiotherapy · Other: Neuromuscular electrical stimulation and voluntary muscle contraction

  • Experimental
    Neuromuscular electrical stimulation + Voluntary muscle contraction

    Experimental Group (NEMS + Voluntary Muscle Contraction) Neuromuscular Electrical Stimulation (NEMS) with Voluntary Muscle Contraction Participants in the experimental group will receive neuromuscular electrical stimulation (NEMS) combined with voluntary muscle contraction of the dorsiflexors. Surface electrodes will be placed over the tibialis anterior, extensor hallucis longus, and extensor digitorum longus muscles. Stimulation parameters will be set as follows: pulse width = 200 microseconds, on time = 5 seconds, off time = 5 seconds, frequency = 20 Hz, waveform = symmetrical biphasic square wave. Participants will be instructed to voluntarily contract the dorsiflexors during each stimulation pulse. The stimulation intensity will be adjusted according to patient comfort to avoid fatigue. Each session will be administered by a trained physiotherapist following the standardized protocol. Any discomfort or adverse response during the procedure will be documented in the patient

    Other: Conventional physiotherapy · Other: Neuromuscular electrical stimulation and voluntary muscle contraction

Interventions

  • OtherConventional physiotherapy

    Conventional physiotherapy Participants in the comparative group will receive conventional physiotherapy treatment including placebo application of neuromuscular electrical stimulation (NEMS), weight-bearing exercises, stretching, proprioceptive neuromuscular facilitation (PNF) techniques, tapping, passive range of motion (PROM) exercises, and dorsiflexor strengthening exercises. The placebo NEMS will be applied in the same manner as the active stimulation but without any therapeutic current. Each session will be supervised by a physiotherapist. Treatment will be conducted as per the study protocol, and all participants' responses, complaints, and discomforts during the sessions will be monitored and recorded using a patient record sheet.

  • OtherNeuromuscular electrical stimulation and voluntary muscle contraction

    Experimental Group (NEMS + Voluntary Muscle Contraction) Neuromuscular Electrical Stimulation (NEMS) with Voluntary Muscle Contraction\<br\>\<br\>Participants in the experimental group will receive neuromuscular electrical stimulation (NEMS) combined with voluntary muscle contraction of the dorsiflexors. Surface electrodes will be placed over the tibialis anterior, extensor hallucis longus, and extensor digitorum longus muscles. Stimulation parameters will be set as follows: pulse width = 200 microseconds, on time = 5 seconds, off time = 5 seconds, frequency = 20 Hz, waveform = symmetrical biphasic square wave. Participants will be instructed to voluntarily contract the dorsiflexors during each stimulation pulse. The stimulation intensity will be adjusted according to patient comfort to avoid fatigue. Each session will be administered by a trained physiotherapist following the standardized protocol. Any discomfort or adverse response during the procedure will be documented in the patient.

06

What researchers measure

Primary outcomes

  1. Modified Ashworth scale

    The Modified Ashworth Scale is a clinical tool used to assess muscle spasticity by measuring resistance during passive soft-tissue stretching. It grades the increase in muscle tone on a scale from 0 to 4, where 0 indicates no increase in muscle tone and 4 indicates the affected part is rigid in flexion or extension. It is a widely used and reliable method for evaluating the severity of spasticity in patients with neurological or musculoskeletal conditions.

    Time frame: 12 weeks

  2. Goniometery

    A goniometer is an instrument that either measures an angle or allows an object to be rotated to a precise angular position.

    Time frame: 12 weeks

  3. Manual muscle testing

    Manual Muscle Testing is a standardized clinical assessment used to evaluate the strength of individual muscles or muscle groups based on the examiner's application of resistance. Muscle strength is graded on a six-point scale (0-5), where 0 indicates no muscle contraction and 5 represents normal strength against full resistance. It is a reliable and widely used method to assess motor function, recovery, and the effectiveness of therapeutic interventions.

    Time frame: 12 weeks

07

Study locations

1 site
  • University of lahore teaching hospital
    Lahore, Punjab Province 54000, Pakistan
08

References and documents

Publications

  • Gillard, J. H., Parrish, T. B., & Mossa-Basha, M. (2021). Stroke imaging advancements. Neuroimaging Clinics of North America, 31(1), 1-17. https://doi.org/10.1016/j.nicna.2020.11.001
  • Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med. 1975;7(1):13-31. PubMed 1135616 ↗
  • Feigin, V. L., Norrving, B., & Mensah, G. A. (2017). Global burden of stroke. The Lancet Neurology, 16(11), 877-897. https://doi.org/10.1016/S1474-4422(17)30283-0
  • Doucet BM, Lam A, Griffin L. Neuromuscular electrical stimulation for skeletal muscle function. Yale J Biol Med. 2012 Jun;85(2):201-15. Epub 2012 Jun 25. PubMed 22737049 ↗
  • Chen, H., Lin, Y., Chen, C., & Tang, Y. (2022). NMES and VMC for dorsiflexion and mobility improvements in chronic stroke. Journal of Neurorehabilitation, 29(6), 378- 387. https://doi.org/10.1016/j.neurorehab.2022.05.004
  • Busk H, Skou ST, Lyckhage LF, Arens CH, Asgari N, Wienecke T. Neuromuscular Electric Stimulation in Addition to Exercise Therapy in Patients with Lower Extremity Paresis Due to Acute Ischemic Stroke. A proof-of-concept randomised controlled trial. J Stroke Cerebrovasc Dis. 2021 Oct;30(10):106050. doi: 10.1016/j.jstrokecerebrovasdis.2021.106050. Epub 2021 Aug 19. PubMed 34418670 ↗
  • Burridge, J., Wood, D., Taylor, P., & Swain, I. (2014). Feasibility study on NMES and VMC for dorsiflexion recovery. Archives of Physical Medicine and Rehabilitation, 95(4), 817-824. https://doi.org/10.1016/j.apmr.2013.12.011
  • Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987 Feb;67(2):206-7. doi: 10.1093/ptj/67.2.206. PubMed 3809245 ↗
  • Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O'Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659. No abstract available. PubMed 30700139 ↗
  • Ahmed, A., et al. (2019). Evaluation of NMES and VMC for ankle control in chronic stroke. Journal of Stroke and Cerebrovascular Diseases, 28(12), 3417-3425.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07458750
Lead sponsor
University of Lahore
Responsible party
Sponsor
First posted
Mar 9, 2026
Start date
Feb 10, 2025
Primary completion
Aug 30, 2026 (estimated)
Completion
Aug 30, 2026 (estimated)
Last update
Jul 15, 2026

Study contacts

Abdul Moiz Hussain Khan, Mspt- neuro
principal investigator · University of Lahore

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion